A Prospective Cohort Study of Basivertebral Nerve Ablation Using the Stryker OptaBlate BVN System for the Treatment of Vertebrogenic Low Back Pain

Inclusion Criteria: * Patient scheduled for treatment with the OptaBlate BVN System in accordance with the device IFU and willing to participate in the clinical investigation, undergo study procedure, engage in follow-up, able to read, write, speak, and understand English, and able to provide written informed consent. Exclusion Criteria: * The patient meets one or more contraindications as defined in the locally applicable IFU * Spinal fracture or history of spinal trauma at index levels * Previous lumbar fusion at any level * Prior basivertebral nerve ablation at the target levels * Vertebral cancer, spinal metastasis or Tumor-related vertebral fractures * History of Osteoporotic vertebral fractures * Spine interventions, including epidural steroid injections within 30 days * BMI \> 40 kg/m² * Symptomatic spinal stenosis * Radicular pain or leg pain greater than back pain * Pregnancy or planning pregnancy during study period * Enrollment in another interventional clinical trial * Contraindication to MRI * Life expectancy of less than 12 months